Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias

Cited by (212)

Items 101–200 of 212

1. Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.
   Linda Ferrington, Laura E. Palmer, Seth Love, Karen J. Horsburgh, Paul At Kelly, Patrick G. Kehoe · 2012 · Europe PMC (PubMed Central)
2. Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention
   Daniel A. Nation, Jean K. Ho, Belinda Yew · 2016 · Journal of Alzheimer s Disease
3. An Update of the Role of Renin Angiotensin in Cardiovascular Homeostasis
   Ehab S. Farag, Kamal Kishore Maheshwari, Joseph W. Morgan, Wael Ali Sakr Esa, Daniel John Doyle · 2015 · Anesthesia & Analgesia
4. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension
   Yi‐Chun Kuan, Kuang-Wei Huang, Der‐Jen Yen, Chaur‐Jong Hu, Cheng‐Li Lin, Chia‐Hung Kao · 2016 · International Journal of Cardiology
5. The KEEPS-Cognitive and Affective Study: Baseline Associations between Vascular Risk Factors and Cognition
   Whitney Wharton, Carey Elizabeth Gleason, N. Maritza Dowling, Cynthia M. Carlsson, Eliot A. Brinton, M. Nanette Santoro, Genevieve Scott Neal-Perry, Hugh Stott Taylor, Frederick Nicholas Naftolin, Rogerio A. Løbo et al. · 2014 · Journal of Alzheimer s Disease
6. Influenza infections and risk of Alzheimer’s disease
   Patrick Imfeld, Stephen Toovey, Susan Sara Jick, Christoph Rudolf Meier · 2016 · Brain Behavior and Immunity
7. Angiotensin II-triggered kinase signaling cascade in the central nervous system
   Anjana Bali, Amteshwar Singh Jaggi · 2015 · Reviews in the Neurosciences
8. Comparison of Antihypertensive Drug Classes for Dementia Prevention
   Venexia M. Walker, Neil M Davies, Richard Michael Martin, Patrick G. Kehoe · 2020 · Epidemiology
9. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects inDrosophila-Expressing Alzheimer’s Disease-Related Transgenes Independently of the Canonical Renin Angiotensin System
   S H Lee, Sarah M. Gomes, Judy Ghalayini, Konstantin G. Iliadi, Gabrielle L. Boulianne · 2020 · eNeuro
10. Renin‐angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease
    Yoshiko Furiya, Miwa Ryo, Makoto Kawahara, Takao Kiriyama, Masami Morikawa, Satoshi Ueno · 2012 · Alzheimer s & Dementia
11. The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats
    Glenda Viggiano Campos, Aline M. A. de Souza, Hong Ji, Crystal Ann West, Xie Wu, Dexter L. Lee, Brittany L. Aguilar, Patrick Alexander Forcelli, Rodrigo Cunha Alvim de Menezes, Kathryn L. Sandberg · 2019 · Cellular and Molecular Neurobiology
12. Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials
    Yasar, Sevil, Schuchman, Mattan, Peters, Jean, Anstey, Kaarin J., Carlson, Michelle C., Peters, Ruth · 2016 · Current Hypertension Reports
13. Associations of Angiotensin Targeting Antihypertensive Drugs with Mortality and Hospitalization in Primary Care Patients with Dementia
    Pat Kehoe, N. Davies, Richard M. Martin, Y. Ben-Shlomo · 2013 · Journal of Alzheimer's Disease
14. Angiotensin Converting Enzyme Inhibitors and Alzheimer Disease in the Presence of the Apolipoprotein E4 Allele
    W. Qiu, A. Lai, Timothy Mon, M. Mwamburi, Warren D. Taylor, J. Rosenzweig, N. Kowall, R. Stern, Hai-Hao Zhu, D. Steffens · 2013 · The American journal of geriatric psychiatry
15. Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer’s Disease
    Patrick G. Kehoe, Noura Al Mulhim, Henrik Zetterberg, Kaj Blennow, James Scott Miners · 2019 · Journal of Alzheimer s Disease
16. Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Naoki Yuda, Miyuki Tanaka, Koji Yamauchi, Fumiaki Abe, Izumi Kakiuchi, Kyoko Kiyosawa, Mitsunaga Miyasaka, Naoki Sakane, Masahiko Nakamura · 2020 · Clinical Interventions in Aging
17. Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways
    Peter J. Attilio, Dustin M. Snapper, Milan Rusnak, Akira J. Isaac, Anthony R. Soltis, Matthew D. Wilkerson, Clifton L. Dalgard, Aviva J. Symes · 2021 · Frontiers in Neuroscience
18. Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R
    Dhanush Haspula, Michelle Alexa Clark · 2018 · Journal of Pharmacology and Experimental Therapeutics
19. Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.
    Thomas O'Hagan, Whitney Wharton, Patrick G. Kehoe · 2012 · Europe PMC (PubMed Central)
20. Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer’s (HEART) Trial
    Whitney Wharton, Felicia C. Goldstein, Malú G. Tansey, Alexandra Lynne Brown, Sonum D. Tharwani, Danielle D. Verble, Amarallys F. Cintron, Patrick G. Kehoe · 2017 · Journal of Alzheimer s Disease
21. Clinical outcomes of COVID‐19 infection among patients with Alzheimer's disease or mild cognitive impairment
    Ying Wang, Mingfei Li, Lewis E. Kazis, Weiming Xia · 2022 · Alzheimer s & Dementia
22. Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons
    Shang‐Der Chen, Chia‐Lin Wu, Tsu‐Kung Lin, Yao‐Chung Chuang, Ding‐I Yang · 2012 · Neurochemistry International
23. Plasma renin–angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer's disease and show gender differences but are not related to apolipoprotein E genotype
    María del Carmen Puertas, José Manuel Martı́nez-Martos, Manuela Cobo, Pedro Lorite, Rosa María Sandalio, Teresa Palomeque, Marı́a Isabel Torres, María Pilar Carrera-González, Marı́a Dolores Mayas, Marı́a Jesús Ramı́rez-Expósito · 2013 · Experimental Gerontology
24. Hypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agents
    António Coca · 2013 · Current Medical Research and Opinion
25. Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study
    Iskandar Tamimi, Belinda Farias Nicolau, Hazem A Eimar, Sreenath Arekunnath Madathil, Abbas Kezouh, Igor Karp, Faleh Tamimi · 2017 · Osteoporosis International
26. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time
    Chris Moran, Kenneth Xie, Su Poh, Sarah Ching Jern Chew, Richard J Beare, Wei Wang, Michele L. Callisaya, Velandai K. Srikanth · 2019 · Journal of Alzheimer s Disease
27. The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease
    Mahdi Montazer Haghighi, Erfan Ghani Kakhki, Christine Sato, Mahdi Ghani, Ekaterina A. Rogaeva · 2020 · Neuroscience Insights
28. Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
    Xinyi Xie, Qianhua Zhao, Qiang Huang, Eric B. Dammer, Shengdi Chen, Ru‐Jing Ren, Gang Wang · 2021 · Genes & Diseases
29. Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions
    Christiane M. Nday, Despoina Eleftheriadou, Graham Ellis Jackson · 2017 · Journal of Neurochemistry
30. Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model
    Filipa Gouveia, Carla Fonseca, Ana Silva, Antoni Camins, Maria Teresa Cruz, Miren Ettcheto, Ana C. Fortuna · 2024 · International Immunopharmacology
31. Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways
    Brice Ongali, Nektaria Nicolakakis, Xin‐Kang Tong, Clotilde Lecrux, Hans Imboden, Édith Hamel · 2018 · Canadian Journal of Physiology and Pharmacology
32. An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease.
    Taner Shakir, Ahmed Yacouba Coulibaly, Patrick G. Kehoe · 2013 · Europe PMC (PubMed Central)
33. Angiotensin II Receptor Blockers in the Management of Hypertension in Preventing Cognitive Impairment and Dementia—A Systematic Review
    Elvira D’Silva, Nur Farah Meor Azlan, Jinwei Zhang · 2022 · Pharmaceutics
34. High-throughput epitope profiling of antibodies in the plasma of Alzheimer’s disease patients using random peptide microarrays
    Sim, Kyu-Young, Park, Sang-Heon, Choi, Kyu Yeong, Park, Jung Eun, Lee, Jung Sup, Kim, Byeong C., Gwak, Jeonghwan, Song, Woo Keun, Lee, Kun Ho, Park, Sung-Gyoo · 2019 · Scientific Reports
35. An update on magnetic resonance imaging markers in AD
    Michela Leocadi, Elisa Canu, Davide Calderaro, Davide Corbetta, Massimo Filippi, Federica Agosta · 2020 · Therapeutic Advances in Neurological Disorders
36. Angiotensin-Converting Enzyme in Cerebrospinal Fluid and Risk of Brain Atrophy
    Hadassa M. Jochemsen, Wiesje M. van der Flier, Emma L. Ashby, Charlotte Elisabeth Teunissen, Ruth E. Jones, Mike Peter Wattjes, Philip Scheltens, Mirjam I. Geerlings, Patrick G. Kehoe, Majon Muller · 2015 · Journal of Alzheimer s Disease
37. Do Angiotensin Receptor Blockers Protect Against Alzheimer’s Disease?
    Hitomi Kurinami, Munehisa Shimamura, Naoyuki Sato, Hironori Nakagami, Ryuichi Morishita · 2013 · Drugs & Aging
38. Renin–angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis
    Shan Zhuang, Jun Li, Xin Wang, Haifeng Wang, Weijie Zhang, Hongyan Wang, Cheng-Ming Xing · 2016 · Neuroscience Letters
39. Antihypertensive Medication Regimen Intensity and Incident Dementia in an Older Population
    Edwin C.K. Tan, Chengxuan Qiu, Yajun Liang, Rui Wang, J. Simon Bell, Johan Fastbom, Laura Fratiglioni, Kristina Johnell · 2018 · Journal of the American Medical Directors Association
40. Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink
    Venexia M. Walker, Neil M Davies, Tim Jones, Patrick G. Kehoe, Richard Michael Martin · 2016 · BMJ Open
41. Addendum: Effect of acetylcholinesterase inhibitors on post-surgical complications and mortality following a hip fracture: a cohort study.
    Iskandar Tamimi, Sreenath Arekunnath Madathil, Abbas Kezouh, Belinda Farias Nicolau, Igor Karp, Faleh Tamimi · 2017 · Europe PMC (PubMed Central)
42. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders
    Yogesh Suresh Ahire, Vinod Ashok Bairagi, Deepak Somavanshi, Smruti R. Jadhav, Swapnil B. Jadhav, Shekhar D. Jagtap · 2024 · Future Journal of Pharmaceutical Sciences
43. Study of the possible effect of sacubitril/valsartan combination versus valsartan on the cognitive function in Alzheimer’s disease model in rats
    Abdallah Salah El-din Hussein, Rahma K. Abo-Elnour, Omayma Anwar Khorshid, Afaf Sayed Osman · 2023 · International Journal of Immunopathology and Pharmacology
44. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer’s disease
    E. V. Kugaevskaya, A. Veselovsky, M. Indeykina, N. I. Solovyeva, M. S. Zharkova, I. Popov, E. Nikolaev, A. Mantsyzov, A. Makarov, S. Kozin · 2018 · Scientific Reports
45. Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia
    Romain Barus, Johana Béné, Julie Deguil, Sophie Gautier, Régis Bordet · 2019 · British Journal of Pharmacology
46. Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
    Nora Hegazy, Samar Rezq, Ahmed Fahmy · 2020 · Neurotherapeutics · Retracted
47. Telmisartan Inhibits TNFα-Induced Leukocyte Adhesion by Blocking ICAM-1 Expression in Astroglial Cells but Not in Endothelial Cells
    Changhwan Jang, Jungjin Kim, Youngsun Kwon, Sangmee Ahn Jo · 2020 · Biomolecules & Therapeutics
48. ACE and ACE2: insights from Drosophila and implications for COVID-19
    Paul Herrera, Ruben J. Cauchi · 2021 · Heliyon
49. The effect of curcumin on blood pressure and cognitive impairment in spontaneously hypertensive rats
    Ji Young Lim, Wookyoung Kim, Ae Wha Ha · 2023 · Nutrition Research and Practice
50. Protective Effects of Angiotensin Receptor Blockers on the Incidence of Dementia in Patients with Chronic Kidney Disease: A Population-Based Nationwide Study
    Yi‐Hsien Chen, Yun‐Yi Chen, Yu‐Wei Fang, Ming‐Hsien Tsai · 2021 · Journal of Clinical Medicine
51. Renin-angiotensin-system increases phosphorylated tau and Reactive Oxygen Species in human cortical neuron cell line
    Luz De Dios, Camille Collazo, Yaritza Inostroza‐Nieves · 2022 · Biochemistry and Biophysics Reports
52. Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study
    Cristina García-García, Lucrecia Moreno, Mónica Alacreu, Francisco Javier Muñoz–Almaraz, Luis A. Martínez · 2022 · International Journal of Environmental Research and Public Health
53. Antihypertensives, angiotensin, glucose and Alzheimer’s disease
    Lucy Nelson, Naji Tabet, Cassie Richardson, Paul Gard · 2013 · Expert Review of Neurotherapeutics
54. Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease
    Judy Ghalayini, Gabrielle L. Boulianne · 2023 · Frontiers in Neuroscience
55. Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4
    Sarah B. Scheinman, Steve Zaldua, Adedoyin Dada, Kateryna Krochmaliuk, Katherine Dye, Felecia M. Marottoli, Gregory R. J. Thatcher, Leon M. Tai · 2021 · Frontiers in Neuroscience
56. Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease
    Noura Al Mulhim, Patrick G. Kehoe, James Scott Miners · 2019 · Acta Neuropathologica Communications
57. Drug Repurposing in Neurological Diseases: Opportunities and Challenges
    Xiao‐Yuan Mao · 2020 · IntechOpen eBooks
58. Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease
    Anatoly L. Mayburd, Ancha V. Baranova · 2013 · BMC Systems Biology
59. The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease.
    Chao‐Liang Chou, Hung‐I Yeh · 2014 · Europe PMC (PubMed Central)
60. Antidepressant-like Effects of Renin Inhibitor Aliskiren in an Inflammatory Mouse Model of Depression
    Sami Ibrahim Alzarea, Hassan H. Alhassan, Abdulaziz Ibrahim Alzarea, Ziad H. Al‐Oanzi, Muhammad Afzal · 2022 · Brain Sciences
61. Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein
    Anna Maria Kanarek, Annika Wagner, Jim Küppers, Michael Gütschow, Rolf Postina, Elżbieta Kojro · 2017 · FEBS Journal
62. FEATURES OF ARTERIAL HYPERTENSION IN PATIENTS WITH COMORBIDITY
    Anna I. Chesnikova, В. А. Сафроненко, N. S. Skarzhinskaya, А. В. Сафроненко, O. E. Kolomatskaya · 2017 · Medical Herald of the South of Russia
63. Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT
    Patrick G. Kehoe, Nicholas L Turner, Beth Howden, Lina Jarutyt, Shona Clegg, Ian B. Malone, Josephine Barnes, Casper F. Nielsen, Carole H. Sudre, Aileen Wilson et al. · 2021 · Efficacy and Mechanism Evaluation
64. Indicators of dementia disease progression in primary care: An electronic health record cohort study
    Trishna Rathod‐Mistry, Michelle Berger Marshall, Paul Campbell, James Bailey, Carolyn Anne Chew-Graham, Peter R. Croft, Martin Frisher, Richard A Hayward, Rashi Negi, Louise A. Robinson et al. · 2020 · European Journal of Neurology
65. Depression as an Inflammatory Disease
    Hoo Rim Song, Woo Young Sup, Won‐Myong Bahk · 2013 · 대한정신약물학회지
66. Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
    Petra E. Spies, Marcel M. Verbeek, Magnus J.C. Sjögren, Frank‐Erik de Leeuw, Jurgen A.H.R. Claassen · 2014 · Current Alzheimer Research
67. Neuronal ACE1 knockout disrupts the hippocampal renin angiotensin system leading to memory impairment and vascular loss in normal aging
    Sohee Jeon, Miranda A. Salvo, Alia O. Alia, Jelena Popović, Mitchell Zagardo, Sidhanth Chandra, Malik M. Nassan, David Gate, Robert J. Vassar, Leah K. Cuddy · 2024 · Neurobiology of Disease
68. Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives
    Kuldeep Kumar, Sonal Aggarwal, Ayush Kandpal, Ramanpreet Kaur, Amteshwar Singh Jaggi, Harlokesh Narayan Yadav, Dhandeep Singh, Dimple Chopra, Nirmal Singh · 2025 · Experimental Brain Research
69. Neuropathology of Traumatic Brain Injury and Its Role in the Development of Alzheimer’s Disease
    Sonia Villapol · 2019 · IntechOpen eBooks
70. Markers of dementia-related health in primary care electronic health records
    Paul Campbell, Trishna Rathod‐Mistry, Michelle Berger Marshall, James Bailey, Carolyn Anne Chew-Graham, Peter R. Croft, Martin Frisher, Richard A Hayward, Rashi Negi, Swaran Preet Singh et al. · 2020 · Aging & Mental Health
71. Research Progress of Alzheimer’s Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis
    Xinquan Li, Wei-ting Xuan, Dabao Chen, Huawu Gao, Guangyun Wang, Qiaoru Guo, Yan Wang, Hang Song, Biao Cai · 2020 · Journal of Alzheimer s Disease
72. Emerging Therapeutic Strategies in Alzheimer's Disease
    Tomohiro Chiba · 2013 · InTech eBooks
73. The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington’s disease in rats: shifting paradigms in Huntington’s disease treatment
    Hanaa Wanas, Mostafa Adel Rabie, Basma Emad Aboulhoda, Nagwa Mahmoud Ramadan, Soha Ezz AlArab Abdel-Wahab, Sara Sayed Kadry Abdallah, Eid Nassar Ali, Leyan Nasruddeen Khayruddeen, Yasir Hassan Elhassan, Hadel Mahroos Alghabban et al. · 2024 · Future Journal of Pharmaceutical Sciences
74. Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan
    Filipa Gouveia, Andreia Carona, Mariana Lacerda, Joana Bicker, Antoni Camins, Maria Teresa Cruz, Miren Ettcheto, Amílcar C. Falcão, Ana C. Fortuna · 2024 · Biochemical Pharmacology
75. Binding of ACE-inhibitors to in vitro and patient-derived amyloid-β fibril models
    Manikanthan Bhavaraju, Malachi Phillips, Deborah Bowman, Juan Manuel Aceves-Hernández, Ulrich H. E. Hansmann · 2016 · The Journal of Chemical Physics
76. Cognitive Dysfunction and Dementia in Animal Models of Hypertension
    Dima Obari, Sefika Ozturk Ozcelik, Hélène Girouard, Édith Hamel · 2016 · Springer eBooks
77. The role of eprosartan in the management of essential hypertension: literature review and expert opinion
    Carlos Escobar, Pilar Mazón, Claudio Rivadulla, Shukrath Chandrappa · 2024 · Expert Review of Cardiovascular Therapy
78. Effect of telmisartan on hypertensive dementia patients: an observational study
    Umashanker Prasad Keshri, Ravi Ranjan, Risi Tuhin Guria, Paramveer Kumar, Kumar Rajnish, Manju Gari · 2020 · International Journal of Basic & Clinical Pharmacology
79. Angiotensin-II stimulating vs. inhibiting antihypertensive drugs and the risk of Alzheimer's disease or related dementia in a large cohort of older patients with colorectal cancer
    Xianglin L. Du, Zhuoyun Li, Paul Ernest Schulz · 2023 · Frontiers in Cardiovascular Medicine
80. Higher Neuronal Facilitation and Potentiation with APOE4 Suppressed by Angiotensin II
    Sarah B. Scheinman, Kuei Yuan Tseng, Simon T. Alford, Leon M. Tai · 2023 · Molecular Neurobiology
81. Hypertension, Cognitive Decline, and Dementia
    Cristina Sierra, Augusto Vicario, Ona Escoda · 2016 · Updates in hypertension and cardiovascular protection
82. Knowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease
    Anatoly L. Mayburd, Ancha V. Baranova · 2017 · Methods in molecular biology
83. Preliminary study of ovariectomy and chronic losartan-induced alterations in brain AT1 receptors
    Danial Mehranfard, Andrea Linares, Alesa Chabbra, Glenda Viggiano Campos, Aline M. A. de Souza, Hong Ji, Crystal Ann West, Kathryn L. Sandberg, Robert Charles Speth · 2021 · Brain Research
84. Degenerative Brain Diseases and White Matter Injury
    George Bartzokis, Po H. Lu · 2013 · Springer eBooks
85. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration
    Suneela Sunil Dhaneshwar, Mohammad Aadil Bhat, Anuradha Singh, Supriya Roy · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
86. How to Prevent Cognitive Decline and Dementia in Hypertension
    António Coca, Augusto Vicario, Pedro Cunha, Gustavo Hernán Cerezo · 2024 · Updates in hypertension and cardiovascular protection
87. Revolutionising Neurological Therapeutics: Investigating Drug Repurposing Strategies
    Meenakshi Attri, Asha Raghav, Jyoti Sinha · 2024 · CNS & Neurological Disorders - Drug Targets
88. Advantages and challenges of using arterial spin labelling MRI to monitor cerebral blood flow in multi-centre clinical trials of neurodegenerative disease: Experience from the RADAR study
    Lina Jarutytė, Jan Petr, Nicholas L Turner, Patrick G. Kehoe, Henk J. M. M. Mutsaerts, David Lee Thomas · 2025 · Cerebral Circulation - Cognition and Behavior
89. Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virus
    Tammy H. Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, Ilya Tyagin, Ilya Safro, Michael D. Wyatt, Michael S. Shtutman, S. Scott Sutton · 2024 · medRxiv
90. Lokalny układ renina-angiotensyna - nowy łącznik pomiędzy mózgiem a tarczycą?
    Mariusz Stasiołek, Andrzej Lewiñski · 2011
91. Meðferðarúrræði við Alzheimerssjúkdómnum : lyf og lyfleysur
    Erla Steinunn Árnadóttir · 2014
92. Untersuchungen zur funktionellen Interaktion zwischen dem Rezeptor Mas und dem AT2-Rezeptor in primären, murinen Astrozyten
    Julia Leonhardt · 2015 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
93. El cerebro y el daño neuropsiquiátrico de la hipertensión arterial
    A. Vicario · 2014 · Hipertensión y Riesgo Vascular
94. Response to the Letter by Sacerdote A., et al
    Wei‐Che Chiu, Yao‐Hsien Tseng, Pau‐Chung Chen · 2015 · The Journal of Clinical Endocrinology & Metabolism
95. Original Article Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse
    Linda Ferrington, Laura E. Palmer, Seth Love, Karen J. Horsburgh, Paul A. Kelly, Patrick G. Kehoe · 2012
96. The Way Forward: Translation
    James L. Kirkland, Tamar Tchkonia · 2015 · Springer eBooks
97. Pharmacological Measures for the Treatment and Prevention of Stroke: The Choice of Initial Therapy
    Sorin Tuță · 2016 · Springer eBooks
98. Review Article Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?
    Rory J Kelleher, Roy Louis Soiza · 2013
99. Effect of angiotensin II receptor blockers and calcium antagonists on cognition
    Ol'ga Dmitrievna Ostroumova, Elena I. Pervichko, N.Yu. Galeeva · 2016 · Meditsinskiy sovet = Medical Council
100. Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
     Ol'ga Dmitrievna Ostroumova, Черняева Марина Сергеевна · 2018 · CARDIOVASCULAR THERAPY AND PREVENTION